Abstract
AIMS: To describe the clinical outcome of three patients with Behçet's disease maintained on infliximab who were switched to adalimumab therapy. METHODS: Case note review. Main outcome measure was recurrence of uveitis. RESULTS: All patients remained free of recurrence with stable visual acuities. CONCLUSIONS: Adalimumab appears to maintain disease remission in Behçet's disease.
| Original language | English |
|---|---|
| Pages (from-to) | 824-5 |
| Number of pages | 2 |
| Journal | Eye |
| Volume | 21 |
| Issue number | 6 |
| Early online date | 7 Apr 2006 |
| DOIs | |
| Publication status | Published - 7 Apr 2006 |